Your browser doesn't support javascript.
loading
Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.
Sánchez Barrueco, Álvaro; Mateos-Moreno, María Victoria; Martínez-Beneyto, Yolanda; García-Vázquez, Elisa; Campos González, Alfonso; Zapardiel Ferrero, Javier; Bogoya Castaño, Abel; Alcalá Rueda, Ignacio; Villacampa Aubá, José Miguel; Cenjor Español, Carlos; Moreno-Parrado, Laura; Ausina-Márquez, Verónica; García-Esteban, Sandra; Artacho, Alejandro; López-Labrador, F Xavier; Mira, Alex; Ferrer, María D.
Afiliação
  • Sánchez Barrueco Á; ENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Mateos-Moreno MV; ENT and Cervicofacial Surgery Department, Villalba General University Hospital, Collado Villalba, Spain.
  • Martínez-Beneyto Y; Department of Dental Clinical Specialties, School of Dentistry, Madrid Complutense University, Madrid, Spain.
  • García-Vázquez E; Department of Dermatology, Stomatology and Radiology, University of Murcia, Murcia, Spain.
  • Campos González A; Murcian Institute of Biosanitary Research (IMIB), Murcia, Spain.
  • Zapardiel Ferrero J; Infectious Diseases Unit, Virgen de la Arrixaca University Clinical Hospital, IMIB, Murcia, Spain.
  • Bogoya Castaño A; ENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Alcalá Rueda I; Microbiology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Villacampa Aubá JM; Villalba General University Hospital, Collado Villalba, Spain.
  • Cenjor Español C; ENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Moreno-Parrado L; ENT and Cervicofacial Surgery Department, Villalba General University Hospital, Collado Villalba, Spain.
  • Ausina-Márquez V; ENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • García-Esteban S; ENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Artacho A; Microbiology Service, Murcian Institute of Biosanitary Research, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain.
  • López-Labrador FX; Department of Dentistry, European University of Valencia, Valencia, Spain.
  • Mira A; Genomics & Health Department, FISABIO-Public Health Foundation, Valencia, Spain.
  • Ferrer MD; Genomics & Health Department, FISABIO-Public Health Foundation, Valencia, Spain.
Emerg Microbes Infect ; 11(1): 1833-1842, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35796097

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Anti-Infecciosos Locais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Anti-Infecciosos Locais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article